Clinicopathological Features and Prognostic Differences Between Primary and Relapsed or Refractory Extramedullary Multiple Myeloma
R/REMM is an independent adverse prognostic factor for patients with MM. Patients with R/REMM are more likely to have plasma cell leukemia and lower albumin levels.
Authors
- Yiyang Li (ORCID: https://orcid.org/0000-0002-2523-7675)
- Mulan Jin
- Xiumei Hu
- Xue Li
- Hongying Zhao
- Xiangyang Dai
- Yanan Qi
- Meng Yang
- Jun Zhou
Institutions
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Fourth People's Hospital of Sichuan Province (CN)
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/cmar.s552024
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00